Molecules to Medicines Seminar Series: Matthew Roe, MD

Matthew Roe, MD, MHS

The Manning Institute, together with the School of Medicine Office for Research and the Enterprise Studio at UVA Licensing & Ventures Group, hosts Molecules to Medicines, a seminar series designed to cultivate and showcase the type of translational investigators who will drive the mission of the Manning Institute.

Join us for the next seminar. And come early for pizza!

Speaker: Matthew Roe, MD, MHS | AstraZeneca | Global Medical Lead | Biopharmaceuticals Research and Development – Early Cardiovascular, Renal, and Metabolism

Topic: Advanced Molecular and Clinical Phenotyping of Key Patient Groups to Drive Drug Development

Molecules to Medicines features nationally recognized external speakers whose work exemplifies the full spectrum of translational science and medicine—individuals who excel at moving discoveries from fundamental molecular insights toward clinical application, therapeutic development, and real-world health impact. These speakers represent the phenotype of investigator that the new Manning Institute aims to foster: interdisciplinary, innovative, impact oriented, and deeply committed to turning scientific advances into meaningful outcomes for patients.

By bringing together visionary scientists, experienced innovators, and members of our research community, Molecules to Medicines will serve as an essential platform for building skills, strengthening collaborations, and accelerating the pace at which discovery leads to better health.

Filed Under: Events